CTNM
Financials
- Market Capitalization 194.5 M
- Employee 51
- Founded 2009
- CEO N/A
- Website www.contineum-tx.com
- Headquarter Delaware, United States
- FIGI BBG01M27SVP6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3537 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.57 USD | -6.01% | -1.94% | -17.87% | -28.28% | 198.78 M USD | ||
| 3541 |  SION Sionna Therapeutics, Inc. - Common Stock | 4.38 USD | -6.61% | -6.41% | -44.35% | -88.87% | 198.03 M USD | ||
| 3556 |  ACOG Alpha Cognition Inc. - Common Stock | 8.80 USD | -0.45% | -1.68% | +2.21% | +24.82% | 191.65 M USD | ||
| 3557 |  IVVD Invivyd, Inc. - Common Stock | 0.65 USD | -2.99% | -18.75% | -26.14% | -61.76% | 191.59 M USD |
Frequently asked questions about Contineum Therapeutics, Inc. Class A Common Stock
What is the Contineum Therapeutics, Inc. Class A Common Stock stock price today?
The current price of Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is 8.42. Over the past 24 hours, the stock has changed by -1.75%. Follow the CTNM chart for real-time price dynamics.
What is the stock ticker of Contineum Therapeutics, Inc. Class A Common Stock?
Contineum Therapeutics, Inc. Class A Common Stock trades under the ticker CTNM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Contineum Therapeutics, Inc. Class A Common Stock stock going up?
CTNM has changed by -32.21% over the last week, -38.81% over the last month, and -44.86% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Contineum Therapeutics, Inc. Class A Common Stock?
Contineum Therapeutics, Inc. Class A Common Stock currently has a market capitalization of 194.5 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Contineum Therapeutics, Inc. Class A Common Stock earnings last quarter?
Last quarter, Contineum Therapeutics, Inc. Class A Common Stock reported earnings of -0.4 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Contineum Therapeutics, Inc. Class A Common Stock net income for the last quarter?
Contineum Therapeutics, Inc. Class A Common Stock reported net income of -15.15 M for the last quarter. The previous quarter showed -14.46 M, which means net income changed by -4.83%.
How many employees does Contineum Therapeutics, Inc. Class A Common Stock have?
As of the latest available data, Contineum Therapeutics, Inc. Class A Common Stock has 51 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Contineum Therapeutics, Inc. Class A Common Stock stock?
You can buy Contineum Therapeutics, Inc. Class A Common Stock (CTNM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Contineum Therapeutics, Inc. Class A Common Stock stock?
Investing in Contineum Therapeutics, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTNM chart and related analysis on metatrader.com as part of your research.